Medication info
Crejet Tablet 10/5 mg (Ezetimibe, Rosuvastatin)

Crejet Tablet 10/5 mg (Ezetimibe, Rosuvastatin)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium Micronized›5.2mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Daewoong Pharmaceutical Co., Ltd.
Appearance
Pink, rectangular, film-coated tablet
Packaging
30 tablets (10 tablets/ PTP x 3), 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201506800 · Approved 2015.09.24 · Insurance code 641606150

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range for this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly; it may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Daewoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B
  • elevated triglycerides
  • elevated non-HDL cholesterol.
View approved original text

This medication is used as an adjunct therapy to lower high total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol levels while increasing HDL cholesterol in patients with primary hypercholesterolemia or mixed dyslipidemia. It is particularly used to reduce the risk of atherosclerotic vascular diseases caused by hypercholesterolemia and is effective when combined with appropriate dietary therapy. Additionally, it is recommended for use when dietary and other non-pharmacological treatments are insufficient. Before treatment, it is important to identify other causes that may cause dyslipidemia, such as diabetes and hypothyroidism, and to undertake necessary treatments. During treatment, total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride levels should be monitored regularly to assess the effectiveness and safety of the therapy. This drug helps effectively control dyslipidemia and reduce the risk of cardiovascular diseases.

How to take

Adult dose

This medicine is administered once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range for this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly; it may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication may pose a risk of muscle problems, so any symptoms such as muscle pain, muscle cramps, or muscle weakness should be reported to a physician immediately. Serious myopathy or rhabdomyolysis may occur; therefore, if these symptoms are severe or CPK levels significantly increase, treatment should be discontinued. Patients with poor liver function or a history of liver disease should undergo regular liver function tests, and if liver enzyme levels rise significantly, administration should be stopped. This medication should also be used with caution in patients with impaired renal function, and it should not be administered in cases of severe renal impairment. Pregnant or potentially pregnant women and nursing mothers should not use this drug, and fertile women should use effective contraception during treatment. Individuals with alcohol dependence, liver abnormalities, elderly patients, and hypothyroid patients, who have a higher risk of muscle problems, should consult a physician before administration. There may be interactions with other drugs; therefore, if there are any other medications being taken, they should be disclosed, particularly avoiding combination with fibrate class drugs. This medication contains lactose, so patients with lactose intolerance should not take it. Caution is advised as dizziness and other symptoms may occur during driving or operating machinery. Regular blood tests, liver function tests, and muscle-related tests during treatment are important to check for abnormalities.

Side effects

nasopharyngitis, dyspepsia, elevated ALT, edema, myalgia, elevated AST, headache, acute pyelonephritis, dry mouth, elevated liver enzymes, abnormal liver function tests, increased blood lactate dehydrogenase, pruritus, upper respiratory infection, elevated blood glucose, increased blood CPK, biliary disorders, chest pain, facial edema, strange sensation, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, dizziness, lethargy, neurodegenerative disorders, positional dizziness, migraine, diabetes, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, tinea unguium, soft tissue inflammation, fatty liver, liver disorders, liver toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, elevated blood cholesterol, increased blood alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cyst, ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, angioedema, edema, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, myositis, rhabdomyolysis, asthenia, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction syndrome with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, sleep disorders, insomnia, nightmares, interstitial lung disease, sexual dysfunction, gynecomastia, fatal liver failure, non-fatal liver failure, memory decline, forgetfulness, amnesia, memory impairment, confusion, severe muscle weakness, ocular myasthenia, chest pain, cough, myalgia, increased CK, constipation, increased AST, asthenia, arthralgia, fatigue, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased blood creatinine, fatigue, abdominal pain, diarrhea, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air and moisture, and it is best to keep it at temperatures between 1 and 30 degrees Celsius. Storing it in this manner will help maintain the medication's effectiveness for a long time.

Appearance and packaging

Appearance

Pink, rectangular, film-coated tablet

Package unit

30 tablets (10 tablets/ PTP x 3), 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.